New

Revisto

The AI engine Fit Assessment

Beta

The company operates in pharma tech by providing AI-powered MLR review solutions for life sciences marketing compliance, enabling faster, compliant release of promotional materials and improved quality.

Blurb

Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for life sciences marketing.

HQ Location

Austin (United States)

Founded

2023

Employees

11 - 50

Total funding raised

$4.00M

Funding Status

Seed, $4.00M, November 18, 2024

We're enabling the next generation of data-driven, personalized, and engaging life sciences marketing through streamlined, AI-powered MLR review technology.



Our mission is to optimize the release cycle, reduce cost, and eliminate compliance risk of releasing promotional materials in the pharmaceutical industry, while improving quality and consistency.



We achieve this by applying deep industry knowledge in cutting-edge technology to automate the compliance requirements and best practices for our customers.



We strive not only to uphold the highest standards of accuracy and compliance, but also to enable the generation of data-driven, personalized, and engaging content that results in positive patient outcomes.



At the heart of our offerings is our AI-driven platform that learns from regulations, industry best practices, and our customers’ historical actions. Recommendations provided by our platform significantly reduce promotional material release time, and this level of efficiency has already earned us the trust of a Top 5 pharmaceutical company.



At Revisto, we believe in transparency and understand that trust is earned through consistent performance and open communication. We are committed to delivering results for our customers and fostering relationships built on mutual respect and shared success.



Join us as we continue to innovate and shape the future of pharmaceutical marketing.